OPKO Health (OPKO Health) Float Percentage Of Total Shares Outstanding

: 53.16% (As of Today)

View and export this data going back to 1995. Start your Free Trial

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, OPKO Health's float shares is 370.50 Mil. OPKO Health's total shares outstanding is 696.99 Mil. OPKO Health's float percentage of total shares outstanding is 53.16%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, OPKO Health's Insider Ownership is 6.75%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, OPKO Health's Institutional Ownership is 17.68%.

OPKO Health Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

OPKO Health's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	370.50	/	696.99
	=	53.16%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OPKO Health (OPKO Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OPKO Health Inc (NAS:OPK) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

OPK:Mexico OPK:Israel XCY:Germany XCY:Germany

Address

4400 Biscayne Boulevard, Miami, FL, USA, 33137

Website

https://www.opko.com

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.

Executives

Frost Phillip Md Et Al	10 percent owner	4400 BISCAYNE BLVD, MIAMI FL 33137-3227
Hsiao Jane Ph D	director	4400 BISCAYNE BLVD, MIAMI FL 33137
Gary J. Nabel	director, officer: Chief Innovation Officer	C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Elias A. Zerhouni	director, officer: Vice Chairman and President	2099 PENNSYLVANIA AVENUE, NW 12TH FLOOR, WASHINGTON DC 20006
John A Paganelli	director, other: Chairman of the Board	OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Steven D Rubin	director	OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Pfenniger Richard C Jr	director	4400 BISCAYNE BLVD., MIAMI FL 33137
Alexis Borisy	director	C/O COMBINATORX, INCORPORATED, 245 FIRST STREET, 16TH FLOOR, CAMBRIDGE MA 02142
Jon R Cohen	director, officer: SVP OPKO; Exec Chairman BRLI	C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Prem A Lachman	director	4400 BISCAYNE BLVD., MIAMI FL 33137
Roger Md Medel	director	1301 CONCORD TERRACE, SUNRISE FL 33323
Rulfo Fernando Hernandez	officer: CAO, Treasurer	C/O OPKO HEALTH INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Anthony J Japour	director	19805 N. CREEK PARKWAY, BOTHELL WA 98011
Robert Scott Fishel	director	C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Adam Logal	officer: Exec.Dir .of Fin., CAO,Treas.	OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137